Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Evaluation Of The Pre-Transplantation Workup Before Allogeneic Transplantation and Reasons For Delaying Or Cancelling Transplant

Sabine Gerull, MD, Andreas S Buser, MD, Christoph Bucher, MD, Dominik Heim, MD, Michael Medinger, MD, Jakob Passweg, MD, Martin Stern, MD

Blood (2013) 122 (21): 5456.

https://doi.org/10.1182/blood.V122.21.5456.5456

Published: 2013

Journal Articles

Negative Impact Of KIR/HLA Interactions On NK Cell Activity Can Be Overcome By The Glycoengineered Antibody GA101 (Obinutuzumab)

Grzegorz Terszowski, PhD, Christian Klein, PhD, Jakob Passweg, MD, Martin Stern, MD

Blood (2013) 122 (21): 376.

https://doi.org/10.1182/blood.V122.21.376.376

Published: 2013

Journal Articles

Impact of Graft-Versus-Host Disease On Relapse After Allogeneic Hematopoietic Stem Cell Transplantation, an EBMT Megafile Study

Martin Stern, MD, Liesbeth C. de Wreede, PhD, Ronald Brand, PhD, Anja van Biezen, Peter Dreger, MD, Mohamad Mohty, MD, PhD, Theo M. de Witte, Nicolaus Kröger, Tapani Ruutu, MD, PhD

Blood (2012) 120 (21): 469.

https://doi.org/10.1182/blood.V120.21.469.469

Published: 2012

Journal Articles

Prognostic Impact of Iron Overload During Follow-up After Allogeneic Stem Cell Transplantation

Sara C. Meyer, MD, PhD, Andreas S. Buser, MD, André Tichelli, MD, Jakob R. Passweg, MD, Martin Stern, MD

Blood (2011) 118 (21): 347.

https://doi.org/10.1182/blood.V118.21.347.347

Published: 2011

Journal Articles

Allogeneic Transplantation for Multiple Myeloma – the Swiss Experience

Sabine Gerull, MD, Yves Chalandon, MD, Markus G Manz, MD, Bilal Mohty, MD, Urs Schanz, MD, Martin Stern, MD, Georg Stussi, MD, Jakob R. Passweg, MD

Blood (2011) 118 (21): 3112.

https://doi.org/10.1182/blood.V118.21.3112.3112

Published: 2011

Journal Articles

Prognostic Impact of Different Iron Parameters In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Godwin Nosakhare Bazuave, MD, Andreas S. Buser, MD, Sabine Gerull, MD, André Tichelli, MD, Martin Stern, MD

Blood (2010) 116 (21): 168.

https://doi.org/10.1182/blood.V116.21.168.168

Published: 2010

Journal Articles

Cyclosporine Levels and Rate of Graft Rejection Following Reduced Intensity Conditioning.

Sabine Gerull, MD, Joerg Halter, Christoph Bucher, Dominik Heim, MD, André Tichelli, MD, Alois Gratwohl, MD, Martin Stern, MD

Blood (2009) 114 (22): 3337.

https://doi.org/10.1182/blood.V114.22.3337.3337

Published: 2009

Journal Articles

High-Dose Melphalan Re-Induction with or without Stem Cell Support Prior to Myeloablative Allogeneic Stem Cell Transplantation in Patients with Advanced Relapsed or Refractory Acute Myeloid Leukemia.

Alix O'Meara, MD, Thomas Pabst, MD, Dominik Heim, MD, Christoph Bucher, MD, Joerg Halter, MD, Caroline Arber, MD, Alicia Rovò, André Tichelli, MD, Alois Gratwohl, MD, Martin Stern, MD

Blood (2009) 114 (22): 2271.

https://doi.org/10.1182/blood.V114.22.2271.2271

Published: 2009

Journal Articles

Late Altered Organ Function in Long Term Survivors after Allogeneic HSCT: A Paired Comparison with Their Identical Sibling Donor

Alicia Rovo, MD, Thomas Daikeler, MD, Joerg Halter, MD, Dominik Heim, MD, Jan Dirk Studt, MD, Michael Medinger, MD, Caroline Arber, MD, Martin Stern, MD, Dimitrios Tsakiris, MD, Alan Tyndall, MD, Alois Gratwohl, MD, Andre Tichelli, MD

Blood (2008) 112 (11): 4298.

https://doi.org/10.1182/blood.V112.11.4298.4298

Published: 2008

Journal Articles

Expansion of Donor NK Cells for Adoptive Immunotherapy in Haploidentical Stem Cell Transplantation: A Phase I–II Study

Uwe Siegler, PhD, Sandrine Meyer-Monard, MD, Simon Jörger, MD, Martin Stern, MD, Andre Tichelli, MD, Alois Gratwohl, MD, Aleksandra Wodnar-Filipowicz, PhD, Christian Kalberer, PhD

Blood (2008) 112 (11): 3893.

https://doi.org/10.1182/blood.V112.11.3893.3893

Published: 2008

Journal Articles

Premature Aging of Hematopoietic Cells in Long Term Survivors after HSCT with Chronic GVHD and a Female Donor.

Gabriela M. Baerlocher, MD, Alicia Rovo, MD, Astrid Mueller, Sybille Matthey, Martin Stern, MD, Joerg Halter, MD, Jan Dirk, MD, Caroline Arber, MD, Alois Gratwohl, MD, Andre Tichelli, MD

Blood (2007) 110 (11): 829.

https://doi.org/10.1182/blood.V110.11.829.829

Published: 2007

Journal Articles

High Dose Chemotherapy Using Beam without Autologous Rescue Followed by Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Refractory or Relapsing Lymphomas - A Comparison of Delayed Versus Immediate Transplantation.

Andreas S. Buser, MD, Martin Stern, MD, Christoph Bucher, MD, Caroline Arber, MD, Dominik Heim, MD, Joerg Halter, MD, Sandrine Meyer-Monard, MD, Georg Stussi, MD, Andreas Lohri, MD, Michele Ghielmini, MD, Andre Tichelli, MD, Jakob R. Passweg, MD, Alois Gratwohl, MD

Blood (2006) 108 (11): 5352.

https://doi.org/10.1182/blood.V108.11.5352.5352

Published: 2006

Journal Articles

Alloreactive Natural Killer Cells Rebuild Adaptive Immunity to Infections after Haploidentical Hematopoietic Transplantation.

Loredana Ruggeri, MD, PhD, Emanuela Burchielli, MD, PhD, Katia Perruccio, MD, PhD, Marusca Capanni, Martin Stern, MD, PhD, Kathrin Hafen, Franco Aversa, MD, Massimo F. Martelli, MD, PhD, Luigina Romani, MD, PhD, George Hollander, MD, PhD, Andrea Velardi, MD, PhD

Blood (2006) 108 (11): 3210.

https://doi.org/10.1182/blood.V108.11.3210.3210

Published: 2006

Journal Articles

Donor Natural Killer Cell Allorecognition of Missing Self in Haploidentical Hematopoietic Transplantation for Acute Myeloid Leukemia: Challenging Its Predictive Value.

Loredana Ruggeri, MD, PhD, Antonella Mancusi, PhD, Marusca Capanni, M.Sc(Biol), Elena Urbani, M.Sc(Biol), Alessandra Carotti, MD, Teresa Aloisi, MD, Martin Stern, MD, Katia Perruccio, MD, PhD, Emanuela Burchielli, MD, PhD, Fabiana Topini, M.Sc(Biol), Erika Bianchi, M.Sc(Biol), Franco Aversa, MD, Massimo F. Martelli, MD, Andrea Velardi, MD

Blood (2006) 108 (11): 437.

https://doi.org/10.1182/blood.V108.11.437.437

Published: 2006

Journal Articles

Preemptive Immunotherapy with Highly Purified CD56+/CD3− Natural Killer Cells after Haploidentical Stem Cell Transplantation. A Prospective Phase II Study in 2 Centers.

Jakob R. Passweg, MD, MS, Ulrike Koehl, PhD, Martin Stern, MD, Torsten Tonn, MD, Sandrine Meyer-Monard, MD, Peter Bader, MD, Johannes Rischewski, MD, Jan Soerensen, MD, Michael Paulussen, MD, Alois Gratwohl, MD, Thomas Klingebiel, MD, Andre Tichelli, MD, Dirk Schwabe, MD

Blood (2006) 108 (11): 411.

https://doi.org/10.1182/blood.V108.11.411.411

Published: 2006

NARROW

Evaluation Of The Pre-Transplantation Workup Before Allogeneic Transplantation and Reasons For Delaying Or Cancelling Transplant

Negative Impact Of KIR/HLA Interactions On NK Cell Activity Can Be Overcome By The Glycoengineered Antibody GA101 (Obinutuzumab)

Impact of Graft-Versus-Host Disease On Relapse After Allogeneic Hematopoietic Stem Cell Transplantation, an EBMT Megafile Study

Prognostic Impact of Iron Overload During Follow-up After Allogeneic Stem Cell Transplantation

Allogeneic Transplantation for Multiple Myeloma – the Swiss Experience

Prognostic Impact of Different Iron Parameters In Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Cyclosporine Levels and Rate of Graft Rejection Following Reduced Intensity Conditioning.

High-Dose Melphalan Re-Induction with or without Stem Cell Support Prior to Myeloablative Allogeneic Stem Cell Transplantation in Patients with Advanced Relapsed or Refractory Acute Myeloid Leukemia.

Late Altered Organ Function in Long Term Survivors after Allogeneic HSCT: A Paired Comparison with Their Identical Sibling Donor

Expansion of Donor NK Cells for Adoptive Immunotherapy in Haploidentical Stem Cell Transplantation: A Phase I–II Study

Premature Aging of Hematopoietic Cells in Long Term Survivors after HSCT with Chronic GVHD and a Female Donor.

High Dose Chemotherapy Using Beam without Autologous Rescue Followed by Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation for Refractory or Relapsing Lymphomas - A Comparison of Delayed Versus Immediate Transplantation.

Alloreactive Natural Killer Cells Rebuild Adaptive Immunity to Infections after Haploidentical Hematopoietic Transplantation.

Donor Natural Killer Cell Allorecognition of Missing Self in Haploidentical Hematopoietic Transplantation for Acute Myeloid Leukemia: Challenging Its Predictive Value.

Preemptive Immunotherapy with Highly Purified CD56+/CD3− Natural Killer Cells after Haploidentical Stem Cell Transplantation. A Prospective Phase II Study in 2 Centers.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only